SEC Form 4Coverage since May 26, 2026
$OTLK insider trading
Over the last 12 months, Outlook Therapeutics insiders reported 7 buys totaling $5.4M and no sales across SEC Form 4 filings.
- Bought · 12m
- $5.4M 7 events
- Sold · 12m
- — 0 events
- Events · 12m
- 7 Form 4 filings, grouped
- Insiders · 12m
- 5 distinct reporters
- 10b5-1 share
- 0% pre-arranged plans
Side
Price · $OTLK · 12Mvia TradingView
Top insiders · 12m
Sukhtian Faisal Ghiath—2× · $150K
Haddadin Yezan Munther—2× · $39K
Sukhtian Ghiath M.—1× · $5.0M
HILZINGER KURT J—1× · $177K
THURMAN RANDY H—1× · $2K
All insider trades
7 events
| Date | Insider | Type | Shares | Avg price | Value | Δ stake | Marks |
|---|---|---|---|---|---|---|---|
| Jul 29, 2026 | Sukhtian Faisal GhiathD | ▲ Buy | 95,398 | $1.05 | $100K | +76% | — |
| Jun 2, 2026 | Haddadin Yezan MuntherD | ▲ Buy | 29,000 | $0.83 | $24K | +78% | — |
| May 28, 2026 | Sukhtian Ghiath M.D·10% | ▲ Buy | 8,539,709 | $0.59 | $5.0M | +63% | indirect |
| May 27, 2026 | Sukhtian Faisal GhiathD | ▲ Buy | 122,174 | $0.41 | $50K | +3593.4% | — |
| May 26, 2026 | Haddadin Yezan MuntherD | ▲ Buy | 34,000 | $0.44 | $15K | +1073.6% | — |
| May 26, 2026 | THURMAN RANDY HD | ▲ Buy | 5,000 | $0.43 | $2K | +843.2% | — |
| May 26, 2026 | HILZINGER KURT JD | ▲ Buy | 400,000 | $0.44 | $177K | +1691% | — |
About Form 4
Corporate insiders — officers, directors and 10%+ owners — must report their trades to the SEC on Form 4 within two business days. We group each filing's transactions into one economic event (a laddered 10b5-1 sale is one event, not 25 rows), flag pre-arranged plans and late filings, and link every event to its AI-scored article in the $OTLK feed.